DONALD TRUMP PREDICTION MARKETS

Deal odds surge as JD Vance leads Polymarket signs
Donald Trump Prediction Markets

Deal odds surge as JD Vance leads Polymarket signs

On Tuesday, Treasury yields slid after talks of a preliminary peace deal between Washington and Tehran, with Polymarket odds rising as traders push for near-term clarity.

Oil sanctions relief odds rise as June 30 deal looms
Donald Trump Prediction Markets

Oil sanctions relief odds rise as June 30 deal looms

On June 15, 2026, oil slumped as Trump signaled Iran deal progress and Hormuz reopening, fueling bets on sanctions relief.

Leading JD Vance Favored in U.S.-Iran Deal Predictor on Polymarket
Donald Trump Prediction Markets

Leading JD Vance Favored in U.S.-Iran Deal Predictor on Polymarket

On June 12, traders noted chatter of a U.S.-Iran peace framework, buoying Indian markets as risk sentiment improves.

Oil Sanction Relief Heads Trump-Iran Market as June 30 Proximity Boosts Odds
Donald Trump Prediction Markets

Oil Sanction Relief Heads Trump-Iran Market as June 30 Proximity Boosts Odds

On June 30, market data shows Oil Sanction Relief priced at about 80% yes, with Troop Withdrawal and Unfreeze Iranian Assets around 70%.

Oil Sanction Relief bets dominate as Iran talks press toward June 30
Donald Trump Prediction Markets

Oil Sanction Relief bets dominate as Iran talks press toward June 30

As talks between the U.S. and Iran move toward a potential agreement by end of June, Tehran signals willingness to discuss curbing nuclear activity and sanctions relief.

Trump Iranian concessions odds edge higher as June 30 nears
Donald Trump Prediction Markets

Trump Iranian concessions odds edge higher as June 30 nears

On June 8, 2026, BYD, Baidu, and Alibaba were added to a U.S. list of entities aiding Beijing’s military.

Maduro Leads Venezuela Bet as Trump Psychedelics Pivot Roils Markets
Donald Trump Prediction Markets

Maduro Leads Venezuela Bet as Trump Psychedelics Pivot Roils Markets

The report notes Trump’s move to accelerate psychedelic therapy research for PTSD, signaling a policy shift with broad implications for health and markets.